01 1Zhejiang Hisun Pharmaceutical
01 1DAPTOMYCIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-23
Pay. Date : 2012-11-23
DMF Number : 26604
Submission : 2012-12-21
Status : Active
Type : II
20
Xellia Pharmaceuticals Aps, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DAPTOMYCIN, with a corresponding US DMF Number 26604.
Remarkably, this DMF maintains an Active status since its submission on December 21, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 23, 2013, and payment made on November 23, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
